Under the leadership of able its chief editors Andrei Gudkov from Roswell Park Cancer Institute and Blagosklonny Mikhail, Oncotarget is a peer-review medical journal that covers research in all disciplines. The reviews are done on a weekly basing and are open to access. The famous journal published by Impact Journals was brought to life in 2010 with oncology in mind but its success saw other disciplines introduced. Other disciplines covered by the journal include Cardiology, Pharmacology, Neuroscience, Endocrinology, Metabolism and Cell Biology among others. The weekly releases are normally printed to meet special demands. In its presentation, the journal follows Index Medicus, Scopus and Science Citations in creating abstract and in indexing.
Working towards a vision of spreading scientific results broadly and making such results readily available, the journal has seen the impact factor (IF) grow from 4.784 with a coverage of 493 cities in 2011 grow to 5.008 and 10452 cities covered in 2016. An analysis of the Web of Science Core Collection done in January of 2017 showed that the journal would experience a rise in the Thomson Reuters 2016 for the Impact Factor during the next summer. Download output styles at Endnote.com
Other drivers of the journal include to capitalize on the impact of research through insightful assessment, to bring together knowledge from different specialties and biomedical fields, to try eliminate certain diseases through research in clinical and basic sciences and to allow brilliant innovations to spread the climax of it all being a life without illness. The journal has prominent scientists sit in its publishing board including Carlo Croce and Andrew Schally; a onetime Nobel Prize winner. Other notable members include Alexander Varshavsky, Stephen J. Elledge, Michael N. Hall and Bert Vogelstein who won the most prestigious award ever- The Breakthrough price.